Medivation (MDVN)

Add to Watchlists
Create an Alert
58.10 +2.33  +4.18% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
MDVN Price Chart
View All Events

MDVN Events

Date Type Description
Feb 27 Misc Q4 2013 Medivation Conference Call
Feb 27 Earnings Q4 2013 Medivation Earnings Results. Estimate: -0.11.
Nov 12 Misc Medivation Announces Third Quarter 2013 Financial Results Teleconference on November 12, 2013
Nov 12 Earnings Medivation Announces Third Quarter 2013 Financial Results. Estimate: -0.30.
Aug 08 Misc Medivation Announces Second Quarter 2013 Financial Results Teleconference on August 8, 2013
Aug 08 Earnings Second Quarter 2013 Financial Results. Estimate: -0.23.
Jun 28 Misc AGM Event for Medivation Inc
May 09 Misc Medivation Announces First Quarter 2013 Financial Results Teleconference on May 9, 2013
May 09 Earnings Medivation Announces First Quarter 2013 Financial Results. Estimate: -0.44.
View All Performance Charts

MDVN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Medivation is up 9.56% over the last year vs S&P 500 Total Return up 21.24%, Astellas Pharma down 4.22%, and Alexion Pharmaceuticals up 51.13%.

Get Quote for

Pro Report PDF for MDVN

Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download MDVN Pro Report PDF
Advertisement

Pro Strategies Featuring MDVN

Did Medivation make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

MDVN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Its product candidates in clinical development are MDV3100, which is in Phase 3 development for the treatment of advanced prostate cancer, and dimebon (latrepirdine), which is in Phase 3 development for the treatment of Alzheimer's disease and Huntington disease. The company was founded by David T. Hung in September 2003 and is headquartered in San Francisco, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
MDVN 58.10 +2.33 +4.18% 4.404B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.